Search database
Filter
210
Text search: neuroscience
Featured
Language
Document type
149
26
20
7
4
1
1
1
1
Countries / Regions
6
6
6
5
5
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
39
25
22
15
9
7
5
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
25
9
6
5
1
1
Toolboxes
150
18
4
4
3
3
3
2
2
2
2
2
1
1
1
1
1

эпидемиологические исследования паркинсонизма

Е.А. Катунина, Ю.Н. Бездольный Российский государственный медицинский университет им. Н.И. Пирогова Кафедра неврологии и нейрохирургии лечебного факультета д.м.н., доцент Е.А. Катунина, к.м.н. Ю.Н. Бездольный (2010) C2
методические рекомендации на тему эпидемиологические исследования паркинсонизма,

Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation

European Monitoring Centre for Drugs and Drug Addiction (2018) C2
An update from the EU Early Warning System
Página actualizada en agosto del 2018: 8/14/18 20 de marzo del 2014

Drug use and road safety

World Health Organization (2016) C_WHO
Psychoactive substance use affects the functioning of the brain and leads to impaired driving
Petersen et al. Int J Ment Health Syst (2016) 10:30 DOI 10.1186/s13033-016-0060-z

SAMHSA’s Concept of Trauma and Guidance for a Trauma-Informed Approach

SAMHSA’s Trauma and Justice Strategic Initiative (2014) C2

Case studies for regulatory approaches to tobacco products

World Health Organization (2018) C_WHO
Menthol in tobacco products
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG) for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool for assessing and managing p ... more
The WHO Regional Office for Europe, the WHO Collaborating Centre on Culture and Health at the University of Exeter (United Kingdom) and the National Institute of Mental Health (Czechia) convened a workshop on culture and reform of mental health care in central and eastern Europe on 2–3 October 201 ... more
World Drug Report 2018 -4-

Treatment of psychostimulant dependence

World Health Organization (2012) C_WHO
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to describe the best treatments and pract ... more
В этой главе мы попытаемся представить современные взгляды на классификацию, эпидемиологию, этиологию, клиническую картину, оценку, прогноз и лечение РАС. Мы надее ... more
Introduction Chapter A.4 2017 edition
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o ... more
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o ... more
Developmental disorders Chapter C.2 2014 Edition
Mood disorders Chapter E.3 2016 edition
Anxiety disorders Chapter F.3
Anxiety disorders Chapter F.5